GKB Ophthalmics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from GKB Ophthalmics Ltd. on BSE

Load latest

GKB Ophthalmics Ltd.

30 Mar 2024

66.72

-0.89%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation ,2015, intimation be and is hereby given that Mr. K.G. Gupta, Promoter ,Director of the Company , has purchased 1900 equity shares aggregating to Rs. 1,67,699.24/- on 27.03.2024 of the Company, on market. Copy of disclosure required under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation,2015, is enclosed herewith. Copy of disclosure received from Mr. K.G.Gupta is also enclosed herewith. Please acknowledge and take the same on record.

pdf

GKB Ophthalmics Ltd.

30 Mar 2024

66.72

-0.89%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation, 2015 (PIT Regulation, 2015), intimation be and is hereby given that Krishna Gopal Gupta & Sons (HUF), has purchased 1397 equity shares aggregating to Rs. 1,23,838.14 /- from 19.02.2024 to 28.03.2024, on market ,which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulation, 2015. However, as a good Corporate Governance measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulation ,2015,is enclosed herewith along with the copy of disclosure received from Krishna Gopal Gupta and Sons-HUF. Please acknowledge and take the same on record.

pdf

GKB Ophthalmics Ltd.

26 Mar 2024

66.72

-0.89%

SAST

GKB OPHTHALMICS LTD. - 533212 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015, as amended from time to time, the "Trading Window" for dealing /trading in the shares of the Company shall remain closed from April 01, 2024, till the completion of 48 hours after the declaration of the financial results of the Company, for the quarter and financial year ended March 31, 2024. Enclosed please find the disclosure. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

20 Mar 2024

66.72

-0.89%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Revised - Regulation 30 Of SEBI ( Listing Obligations And …

BSE India

Pursuant to Regulation 30 , SEBI ( Listing Obligations and Disclosure Requirements) Regulations 2015, enclosed please find the revised disclosure pertaining to the resignation of Mr. Subhash Redkar as Executive / Whole Time Director due to his immediate appointment without any Notice period as Principal in Industrial Training Institute, Senior Gazetted Officer, in Government of Goa and thereby resulting in delay in intimation. Enclosed is the resignation of Mr. Subhash Redkar. The Board of Directors in its meeting held on March 19, 2024, accepted the said resignation and reconstituted the Committees of the Board as per the enclosed disclosure. We regret the inconvenience caused and request to take the above information record.

pdf

GKB Ophthalmics Ltd.

19 Mar 2024

66.72

-0.89%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India ( Listing Obligations and Disclosure Requirements) Regulations, 2015 enclosed please find the disclosure pertaining to the resignation of Mr. Subhash Redkar as Executive / Whole Time Director of the Company w.e.f. March 16, 2024. The Board of Director in its meeting held today, i.e. March 19, 2024, accepted the resignation of Mr. Subhash Redkar as Executive/ Whole Time Director of the Company and thereafter reconstituted the Committees of the Board. The said details and a copy of the resignation letter is enclosed as Annexure A. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

19 Mar 2024

66.72

-0.89%

Company Update

GKB OPHTHALMICS LTD. - 533212 - OUTCOME OF INDEPENDENT DIRECTORS'' MEETING HELD ON MARCH 19, 2024

BSE India

A separate meeting of the Independent Directors of the Company for the year 2023-24 was held pursuant to Regulation 25(3) of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations, 2015 and Section 149(8) of the Companies Act, 2013, read with Schedule IV(VII). All the Independent Directors were present. The details of the business transacted are enclosed. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

16 Feb 2024

66.72

-0.89%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Extract Of Statement Of Unaudited Standalone And Consolidated Financial Results …

BSE India

Please find attached copies of newspaper cuttings of the extract of the Unaudited Standalone and Consolidated Financial results for the quarter and nine months ended December 31, 2023 published in The Financial Express ( Mumbai Edition) and on Pudhari ( Marathi) dated February 16, 2024.

pdf

GKB Ophthalmics Ltd.

14 Feb 2024

66.72

-0.89%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI …

BSE India

Pursuant to Regulation 32 of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations , 2015 , enclosed please find the Statement of Deviation or Variation for the quarter ended December 31, 2023.

pdf

GKB Ophthalmics Ltd.

14 Feb 2024

66.72

-0.89%

Board Meeting

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Outcome for Outcome Of Board Meeting Of GKB …

BSE India

The meeting of the Board of Directors of the Company was held on February 14, 2024, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31, 2023. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter and nine months ended December 31, 2023, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter and nine months ended December 31, 2023, together with the Limited Review Report. The Board of Directors'' Meeting started at 4.45 P.M. and ended at 06.25 P.M., on the same day. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

30 Jan 2024

66.72

-0.89%

Board Meeting

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Intimation for Considering And Taking On Record The …

BSE India

GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2023. The Notice can be accessed at the Company''s website at www.gkb.net Further, notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) Regulations, 2015, which has been closed, will now re-open on Monday, February 19, 2024. This communication has been sent to all the Directors and all the designated employees of the Company.

pdf

Is GKB Ophthalmics Ltd. worth buying?

12 Votes:

Buy 66.67%

Sell 33.33%